Our Team

Scientists Who Live in the Problem

Pathologists, computational biologists, and AI engineers who understand both the biology of IHC staining and the ML required to quantify it reliably.

Dr. Mei Lin

CEO & Co-Founder

Computational pathologist turned founder. Trained in digital pathology and saw first-hand how manual IHC scoring variability affects treatment decisions. PhD in Biomedical Informatics.

Dr. Alex Rowan

CTO & Co-Founder

Computational imaging engineer. Former postdoctoral researcher in digital pathology at a cancer research institute in San Diego. Built the tiling and feature extraction architecture that powers Synthia's analysis pipeline.

Dr. Priya Nair

Head of Pathology Science

Board-certified anatomic pathologist, subspecialty in breast and GI oncology. Leads annotator training and clinical validation study design. Defines the ground-truth standard for every biomarker scoring task.

Daniel Chase

Lead ML Engineer

Deep learning researcher focused on medical imaging segmentation and quantification. Specialist in vision transformers for histopathology. Designed Synthia's hybrid convolutional-attention model and training protocol.

Work With a Team That Understands Pathology

Questions about our methodology, team expertise, or how we might work with your lab? Reach out to [email protected].